Ad
BMY Quote Trading Chart Bristol-Myers Squibb Company
$74.045 Last:
-1.18% Change Percent:
$75.45 Open:
$74.93 Previous Close:
$75.5 High:
$74.02 Low:
2,632,499 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BMY Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-15 | 75.45 | 74.93 | 75.5 | 74.02 | 2,632,499 |
| 2022-08-12 | 74.58 | 74.93 | 75.72 | 74.57 | 6,162,816 |
| 2022-08-11 | 74.39 | 74.93 | 75.52 | 74.28 | 6,141,203 |
| 2022-08-10 | 75.2 | 74.93 | 75.32 | 73.95 | 8,317,596 |
| 2022-08-09 | 74.1 | 74.93 | 75.515 | 74.06 | 8,978,661 |
| 2022-08-08 | 72.07 | 74.93 | 73.83 | 71.9 | 9,729,159 |
| 2022-08-05 | 71.98 | 74.93 | 72.36 | 71.71 | 8,964,964 |
| 2022-08-04 | 72.79 | 74.93 | 72.95 | 71.975 | 8,592,163 |
| 2022-08-03 | 73.3 | 74.93 | 73.51 | 72.6001 | 8,671,723 |
| 2022-08-02 | 74.18 | 74.93 | 74.73 | 73.24 | 7,038,812 |
| 2022-08-01 | 73.76 | 74.93 | 74.26 | 73.2999 | 6,782,172 |
| 2022-07-29 | 74.45 | 74.93 | 74.65 | 73.17 | 13,446,980 |
| 2022-07-28 | 74.93 | 74.93 | 75.16 | 73.22 | 9,211,322 |
| 2022-07-26 | 73.47 | 73.47 | 74.06 | 72.96 | 3,951,597 |
| 2022-07-19 | 74.12 | 73.14 | 74.29 | 72.915 | 11,396,355 |
| 2022-07-18 | 75.8 | 73.74 | 75.8 | 73.49 | 8,666,024 |
| 2022-07-15 | 74.82 | 75.65 | 75.67 | 74.29 | 10,682,480 |
| 2022-07-14 | 73.64 | 74.01 | 74.125 | 73.24 | 9,597,070 |
| 2022-07-13 | 74.64 | 74.53 | 75.22 | 74.41 | 8,561,781 |
| 2022-07-12 | 75.43 | 75.01 | 75.96 | 74.86 | 9,277,752 |
Bristol-Myers Squibb Company Company Name:
BMY Stock Symbol:
NYSE Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
It can be scary to put your hard-earned money into a bear market. But it is the right time for growth-oriented investors with a long-term horizon to pounce. Interestingly, there are some stocks, such as biotech companies Exelixis (NASDAQ: EXEL) and Bristol-Myers Squibb (NYSE: ...
-
In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill them. Simply put, it means failing to start or intensify a therapy when appropriate, which leads to advanced or chronic disea...
-
Some dividend stocks are better than others. The differentiator is how strong the underlying businesses are that make the dividends possible. We asked three Motley Fool contributors to pick unstoppable dividend stocks to buy in August. Here's why they chose AbbVie (NYSE: ABBV) ,...